Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Nobuaki Fukushima"'
Autor:
Yuma Kawamura, Nako Uchibori, Tomoya Arakawa, Tomoki Fujii, Shuto Negishi, Shiori Morikawa, Nobuaki Fukushima, Akio Kohno, Souichi Yamada, Yoshiko Fukui, Shuetsu Fukushi, Kazutaka Ozeki
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 616-619 (2024)
Abstract A 34‐year‐old woman received umbilical cord blood transplantation for refractory T‐cell prolymphocytic leukemia after salvage therapy with alemtuzumab. She developed right angular cheilitis on the 46th day after transplantation, which
Externí odkaz:
https://doaj.org/article/1a156c82a56f411db43dc5c8aac70f9a
Autor:
Ken Sagou, Makoto Ito, Yuma Kawamura, Shun Ukai, Miyo Goto, Nobuaki Fukushima, Kazutaka Ozeki, Ryuichi Fukuyama, Akio Kohno
Publikováno v:
Clinical Case Reports, Vol 9, Iss 2, Pp 878-882 (2021)
Abstract BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor burden, such as high white blood cell count or splenomegaly, should be carefully considered to prevent T
Externí odkaz:
https://doaj.org/article/d656c0953ef6444f83ce58bd49861b1a
Autor:
Shun Ukai, Miyo Goto, Yuma Kawamura, Makoto Ito, Akio Kohno, Shiori Iida, Ken Sagou, Kazutaka Ozeki, Nobuaki Fukushima
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 10:183-189
Autor:
Akio Kohno, Ryuichi Fukuyama, Miyo Goto, Yuma Kawamura, Kazutaka Ozeki, Ken Sagou, Makoto Ito, Nobuaki Fukushima, Shun Ukai
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 2, Pp 878-882 (2021)
Clinical Case Reports, Vol 9, Iss 2, Pp 878-882 (2021)
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor burden, such as high white blood cell count or splenomegaly, should be carefully considered to prevent TLS.
Publikováno v:
International Journal of Hematology. 113:63-72
Tacrolimus (TAC) is essential for prophylaxis of acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic cell transplantation (allo-HSCT). We have sometimes observed large fluctuations in TAC concentration. However, links between the v
Publikováno v:
International Journal of Hematology. 112:697-706
One major cause of treatment-related death is transplant-associated thrombotic microangiopathy (TA-TMA). Because of difficulties with diagnosis, many criteria for TA-TMA have been defined. Some patients clinically suspected as TA-TMA have been treate
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1005-1012
Permanent impairment (PI) of vital organs is one of the transplantation-related health problems affecting the quality of life and morbidity even in patients who do not develop graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2287-2296
Nutritional status is an important component of cancer care, and malnutrition itself can cause death in 10% to 20% of cancer patients. A nutritional risk index (NRI) is a useful tool for nutritional assessment of cancer patients. This study aimed to
Autor:
Miyo, Goto, Nobuaki, Fukushima, Shiori, Iida, Makoto, Ito, Yuma, Kawamura, Shun, Ukai, Ken, Sagou, Ryuichi, Fukuyama, Akio, Kohno, Kazutaka, Ozeki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(4)
Acute myeloid leukemia (AML) associated with double-minute chromosomes (dmin) is a rare condition and has a poor prognosis. A 68-year-old man with leukocytosis and thrombocytopenia was admitted to our hospital. Bone marrow aspiration showed that 79.5
Publikováno v:
International Journal of Hematology. 109:440-450
The combination of methotrexate (MTX) and a calcineurin inhibitor is widely used for GVHD prophylaxis in umbilical cord blood transplantation (UCBT). However, the optimal MTX dosage for GVHD prophylaxis in UCBT remains unclear. In the present study,